EUVIMEDEUVIMED entdecken
Crossref

Live vaccines following intravenous immunoglobulin for Kawasaki disease: Are we vaccinating appropriately?

Cassandra Cardenas-Brown iD, Ryan D Lucas iD, Jim Buttery, Philip N Britton iD, Nicholas Wood, Davinder Singh-Grewal iD, David Burgner iD

Journal of Paediatrics and Child Health · 2023

DOI: 10.1111/jpc.16484 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Paediatrics and Child Health, 2023. Verfasst von Cassandra Cardenas-Brown und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, The Sydney Children's Hospitals Network Randwick and Westmead, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Mumps, Mucocutaneous Lymph Node Syndrome, Chickenpox, Measles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Australian and New Zealand guidelines recommend that live vaccines be postponed for 11 months after treatment of Kawasaki disease (KD) with intravenous immunoglobulin (IVIG). We aimed to describe patterns of live‐vaccine administration after KD treatment, focusing on the measles–mumps–rubella/measles–mumps–rubella–varicella (MMR/MMRV) vaccines, and to compare real‐world practice with current recommendations.

Methods

We combined data from inpatient Electronic Health Records and the Australian Immunisation Register for all children who received IVIG for the treatment of KD under the age of 5 years at two Australian tertiary children's hospitals over a 12‐year period. Children who received IVIG

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MumpsMucocutaneous Lymph Node SyndromeChickenpoxMeaslesRubellaChildHumansInfantChild, PreschoolImmunoglobulins, IntravenousAustraliaChickenpox VaccineMeasles-Mumps-Rubella VaccineHerpesvirus 3, Human

Stichwörter der Autor:innen

Kawasaki diseaseimmunisationintravenous immunoglobulin

Substanzen

Immunoglobulins, IntravenousChickenpox VaccineMeasles-Mumps-Rubella Vaccine

Autor:innen und Institutionen

  • Department of Rheumatology, The Sydney Children's Hospitals Network Randwick and Westmead, Sydney, New South Wales, Australia.
  • Department of General Medicine, The Sydney Children's Hospitals Network Randwick and Westmead, Sydney, New South Wales, Australia.
  • Discipline of Child and Adolescent Health, The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia.
  • Infection and Immunity Theme, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
  • Melbourne Medical School, Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.
  • Centre for Health Analytics, Melbourne Children's Campus, Melbourne, Victoria, Australia.

ORCID-Profile: Cassandra Cardenas-Brown, Ryan D Lucas, Philip N Britton, Davinder Singh-Grewal, David Burgner

Zitieren

APA

Cardenas-Brown, C., Lucas, R. D., Buttery, J., Britton, P. N., Wood, N., Singh-Grewal, D., & Burgner, D. (2023). Live vaccines following intravenous immunoglobulin for Kawasaki disease: Are we vaccinating appropriately?. Journal of Paediatrics and Child Health. https://doi.org/10.1111/jpc.16484

Vancouver

Cardenas-Brown C, Lucas RD, Buttery J, Britton PN, Wood N, Singh-Grewal D, et al. Live vaccines following intravenous immunoglobulin for Kawasaki disease: Are we vaccinating appropriately?. Journal of Paediatrics and Child Health. 2023. doi:10.1111/jpc.16484

BibTeX
@article{CardenasBrown2023,
  author = {Cardenas-Brown, Cassandra and Lucas, Ryan D and Buttery, Jim and Britton, Philip N and Wood, Nicholas and Singh-Grewal, Davinder and Burgner, David},
  title = {Live vaccines following intravenous immunoglobulin for Kawasaki disease: Are we vaccinating appropriately?},
  journal = {Journal of Paediatrics and Child Health},
  year = {2023},
  doi = {10.1111/jpc.16484}
}
Kostenlos starten →